These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 19217514)
1. Other therapies for reducing low-density lipoprotein cholesterol: medications in development. Stein EA Endocrinol Metab Clin North Am; 2009 Mar; 38(1):99-119. PubMed ID: 19217514 [TBL] [Abstract][Full Text] [Related]
2. The ebbs and flows in the development of cholesterol-lowering drugs: prospects for the future. Hajhosseiny R; Sabir I; Khavandi K; Wierzbicki AS Clin Pharmacol Ther; 2014 Jul; 96(1):64-73. PubMed ID: 24699033 [TBL] [Abstract][Full Text] [Related]
3. Novel therapeutic agents for lowering low density lipoprotein cholesterol. Joy TR Pharmacol Ther; 2012 Jul; 135(1):31-43. PubMed ID: 22465160 [TBL] [Abstract][Full Text] [Related]
5. Novel therapies and new targets of treatment for familial hypercholesterolemia. Goldberg AC J Clin Lipidol; 2010; 4(5):350-6. PubMed ID: 21122677 [TBL] [Abstract][Full Text] [Related]
11. Low-density lipoprotein lowering in 2013 by nonstatin agents: the discovery and development of promising novel targeted therapies. Kohli P; Giugliano RP J Cardiovasc Pharmacol Ther; 2013 May; 18(3):199-210. PubMed ID: 23580658 [TBL] [Abstract][Full Text] [Related]
12. Advancing therapy for hypercholesterolemia. Toutouzas K; Drakopoulou M; Skoumas I; Stefanadis C Expert Opin Pharmacother; 2010 Jul; 11(10):1659-72. PubMed ID: 20509773 [TBL] [Abstract][Full Text] [Related]
13. New lipid-lowering drugs: an update. Wierzbicki AS; Hardman TC; Viljoen A Int J Clin Pract; 2012 Mar; 66(3):270-80. PubMed ID: 22340447 [TBL] [Abstract][Full Text] [Related]
14. Lipid parameters and cardiovascular events in patients taking statins. Brook RD; Rubenfire M JAMA; 2012 Jul; 308(2):132; author reply 132-3. PubMed ID: 22782403 [No Abstract] [Full Text] [Related]
15. Lipid parameters and cardiovascular events in patients taking statins. Martin SS; Jones SR JAMA; 2012 Jul; 308(2):131-2; author reply 132-3. PubMed ID: 22782402 [No Abstract] [Full Text] [Related]
16. New lipid-lowering agents acting on LDL receptors. Scharnagl H; März W Curr Top Med Chem; 2005; 5(3):233-42. PubMed ID: 15857307 [TBL] [Abstract][Full Text] [Related]
17. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting. Cziraky MJ; Watson KE; Talbert RL J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279 [TBL] [Abstract][Full Text] [Related]
18. Mipomersen: a safe and effective antisense therapy adjunct to statins in patients with hypercholesterolemia. Ricotta DN; Frishman W Cardiol Rev; 2012; 20(2):90-5. PubMed ID: 22293857 [TBL] [Abstract][Full Text] [Related]
19. [Statins remain the standard. New methods for lipid lowering therapy]. Aumiller J MMW Fortschr Med; 2001 Oct; 143(42):16-7. PubMed ID: 11697281 [No Abstract] [Full Text] [Related]
20. Impact of nonprescriptive factors on low-density lipoprotein cholesterol reduction with statins. Frolkis JP; Pearce GL; Sprecher DL Am J Cardiol; 2004 Nov; 94(10):1310-2. PubMed ID: 15541255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]